Adaptimmune Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $0 | 592 | 0.00 |
| 2023-09-30 | $15k | 19k | 0.79 |
| 2023-06-30 | $0 | 159 | 0.00 |
| 2022-12-31 | $0 | 29 | 0.00 |
| 2022-09-30 | $0 | 87 | 0.00 |
| 2021-03-31 | $16k | 3.0k | 5.33 |
| 2020-12-31 | $16k | 3.0k | 5.33 |
| 2020-06-30 | $10k | 1.0k | 10.00 |
| 2020-03-31 | $6.2k | 1.9k | 3.17 |
| 2019-12-31 | $2.9k | 3.1k | 0.95 |
| 2019-09-30 | $3.0k | 2.0k | 1.50 |
| 2019-03-31 | $11k | 2.2k | 5.10 |
| 2018-12-31 | $12k | 2.0k | 6.00 |
| 2018-09-30 | $14k | 1.0k | 14.00 |
| 2018-06-30 | $12k | 1.0k | 12.00 |
| 2018-03-31 | $0 | 1.0k | 0.00 |
| 2017-12-31 | $0 | 65 | 0.00 |